🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseHas anyone dealt with doctor said my fatty liver is gone - i literally cried? Page 4

Has anyone dealt with doctor said my fatty liver is gone - i literally cried?

MASHdoc_SA Fri, Nov 28, 2025 at 6:08 PM 33 replies 1,013 viewsPage 4 of 7
denise_HTX
Member
145
678
Jan 2025
Houston, TX
Nov 28, 2025 at 11:48 PM#16

Just wanted to say — for anyone reading this Has anyone dealt thread who is feeling discouraged: it gets better. The first few weeks are the hardest. Hang in there. 💪

30 12sarah.morrison, NeuroNate, JessicaH_TX and 27 others
Reply Quote Save Share Report
NeuroNate
Senior Member
2,890
16,789
Dec 2023
Chicago, IL
Nov 29, 2025 at 12:05 AM#17

MASHdoc_SA's experience with Has anyone dealt with resonates deeply with mine. I went through almost the identical process — starting dose, titration timeline, side effects, everything.

The main difference: I titrated faster. But the overall trajectory has been remarkably similar. Down 64 lbs in 9 months.

One thing I would add that MASHdoc_SA did not mention: the relationship with food fundamentally changed.

2 6wendy_avl, jason_paloalto
Reply Quote Save Share Report
NauseaFreeNow
Member
345
1,234
Aug 2024
Indiana
Nov 29, 2025 at 12:22 AM#18

Saving this for reference. Quality thread.

14 9Dr.PulmRoch, maya_sedona, stefan_berlin and 11 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
LibrarianMeg
Senior Member
1,678
7,890
Mar 2024
Baltimore, MD
Nov 29, 2025 at 12:39 AM#19

As a healthcare provider, I want to add some clinical context to this discussion on Has anyone dealt with doctor said my.

Building on what MASHdoc_SA said — the evidence base here is well-established. The key publications to reference are from the SURMOUNT program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
48 1JessicaM_2024, TomFromTexas, mike.trainer_LA and 45 others
Reply Quote Save Share Report
MikeKY_noInsulin
Member
267
1,234
Oct 2024
Louisville, KY
Nov 29, 2025 at 12:56 AM#20

Subscribing to this thread. Has anyone dealt with is exactly what I've been researching. 🙏

20 21bbq_ray_KC, oliver_london, tane_welly and 17 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register